Cell Source
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cell Source generated cash of -$2,347,891, which is more than the previous year. Cash used in financing activities reached the amount of $2,147,429 last year. Net change in cash is therefore -$200,462.
Cash Flow
| 2014 | -3.11M | -2.58K | 3.11M |
|---|---|---|---|
| 2015 | -2.00M | 0 | 1.98M |
| 2016 | -1.49M | 0 | 1.49M |
| 2017 | -2.28M | 0 | 2.65M |
| 2018 | -2.00M | 0 | 1.65M |
| 2019 | -2.58M | 0 | 2.59M |
| 2020 | -2.77M | 0 | 2.99M |
| 2021 | -3.37M | 0 | 3.22M |
| 2022 | -3.13M | 0 | 3.26M |
| 2023 | -2.34M | 0 | 2.14M |
CLCS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 222.66K | 93.09K | 245.11K | 27.90K | 18.93K | 371.04K | 3.73K | 6.94K | 19.48K | 28.87K |
Operating activities | ||||||||||
Net income | -5.32M | -5.16M | -5.47M | -4.56M | -4.47M | -2.11M | -3.08M | -967.78K | -2.50M | -4.05M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 285.3B | 731.50B | 301.25B | 14.97B | 209.65B | 407 | 860 | 860 | 455 |
Stock-based compensation expense | 445.34K | 77.88K | 419.40K | 791.66K | 844.12K | 0 | 44.71K | 114.75K | 135.88K | 944.3K |
| Deferred income tax benefit | 445.34K | 77.88K | 419.40K | 791.66K | 844.12K | 0 | 44.71K | 114.75K | 135.88K | 944.3K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 786.72K | 457.28K | 29.94K | 57.68K | -142.37K | 75.96K | -17.27K | 99.23K | 323.85B | 28.48B |
Cash generated by operating activities | -2.34M | -3.13M | -3.37M | -2.77M | -2.58M | -2.00M | -2.28M | -1.49M | -2.00M | -3.11M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.58K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.58K |
Financing activities | ||||||||||
Common Stock Issued | 799.91K | 0 | 0 | 730.34K | 1.79T | 1.05T | 2.29T | 0 | 71.4B | 3.01M |
Payments for dividends | 0 | 0 | 0 | 0 | -741.98B | 0 | -240.55B | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -1.05T | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 1.62M | 3.29M | -328.08K | -901.5K | 715K | -500K | 360K | -50K | 1.57M | -100K |
Cash used in financing activities | 2.14M | 3.26M | 3.22M | 2.99M | 2.59M | 1.65M | 2.65M | 1.49M | 1.98M | 3.11M |
Net Change In Cash | -200.46K | 129.57K | -152.02K | 217.21K | 8.97K | -352.11K | 367.31K | -3.20K | -12.53K | -9.39K |
Cash at end of period | 22.20K | 222.66K | 93.09K | 245.11K | 27.90K | 18.93K | 371.04K | 3.73K | 6.94K | 19.48K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |